![Hui Jun Wang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hui Jun Wang
Director Ejecutivo en
OBI PHARMA, INC.
.
Perfil
Hui Jun Wang is currently Chief Executive Officer at OBI Pharma, Inc. and Chairman at Obigen Pharma, Inc. since 2023.
Formerly, served as Vice President & Global Head-Regulatory Science at Bristol-Myers Squibb (Taiwan) Ltd. Earned a doctorate from the University of Notre Dame.
Cargos activos de Hui Jun Wang
| Empresas | Cargo | Inicio |
|---|---|---|
| OBIGEN PHARMA INC. | Presidente | 29/12/2023 |
| OBI PHARMA, INC. | Director Ejecutivo | - |
Antiguos cargos conocidos de Hui Jun Wang.
| Empresas | Cargo | Fin |
|---|---|---|
Bristol-Myers Squibb (Taiwan) Ltd. | Corporate Officer/Principal | - |
Formación de Hui Jun Wang.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
21
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb (Taiwan) Ltd. | |
OBI Pharma, Inc.
 OBI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures anti-infective and immunotherapy drugs | Health Technology |
Obigen Pharma, Inc.
 Obigen Pharma, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures botulinum toxin products | Health Technology |
- Bolsa de valores
- Insiders
- Hui Jun Wang
